Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Author： van Woensel Matthias   Wauthoz Nathalie   Rosière Rémi   Amighi Karim   Mathieu Véronique   Lefranc Florence   van Gool Stefaan W.   de Vleeschouwer Steven  

Publisher： MDPI

E-ISSN： 2072-6694|5|3|1020-1048

ISSN： 2072-6694

Source： Cancers, Vol.5, Iss.3, 2013-08, pp. : 1020-1048

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain Tumors

By Taki Hiroyuki   Kanazawa Takanori   Akiyama Fuminari   Takashima Yuuki   Okada Hiroaki  

Pharmaceuticals, Vol. 5, Iss. 10, 2012-10 ,pp. : 1092-1102

MDPI

Access to resources Recommend Favorite

Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives

By Xu Yingying   Yuen Pak-Wai   Lam Jenny Ka-Wing  

Pharmaceutics, Vol. 6, Iss. 3, 2014-07 ,pp. : 378-415

MDPI

Access to resources Recommend Favorite

Pharmacological Agents Targeting the Cellular Prion Protein

By Barreca Maria Letizia   Iraci Nunzio   Biggi Silvia   Cecchetti Violetta   Biasini Emiliano  

Pathogens, Vol. 7, Iss. 1, 2018-03 ,pp. : 27-27

MDPI

Access to resources Recommend Favorite

Immunogenicity of a West Nile Virus DIII-Cholera Toxin A2/B Chimera after Intranasal Delivery

By Tinker Juliette K.   Yan Jie   Knippel Reece J.   Panayiotou Panos   Cornell Kenneth A.  

Toxins, Vol. 6, Iss. 4, 2014-04 ,pp. : 1397-1418

MDPI

Access to resources Recommend Favorite

Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases

By Shum Ka-To   Zhou Jiehua   Rossi John J.  

Pharmaceuticals, Vol. 6, Iss. 12, 2013-11 ,pp. : 1507-1542

MDPI

Access to resources Recommend Favorite